Shortly after graduating from Fox, Bokhari took a distressed New Jersey medical diagnostics company, Lakewood Pathology Associates, and rebuilt it into one of South Jersey’s fastest growing enterprises, which he sold in 2006 for $50 million to Water Street Healthcare Partners. He then led Parkway Clinical Laboratories, a diagnostic provider of addiction screening and opioid prescription monitoring. Parkway merged in 2008 with Rosetta Genomics (ROSG), a global biotech R&D company. Currently, Bokhari is chairman of the merged Parkway, is a managing partner of private equity fund RBx Capital, and serves as vice chairman of the World Affairs Council of Philadelphia.